In a multivariable analysis , dose-volume parameters were tested together with patient - and treatment-related parameters ( age , smoking , diabetes , cardiovascular disease , tumor stage , neo-adjuvant androgen deprivation , conformal vs. conventional and rectal bleeding during treatment ) .
